https://orcid.org/0000-0003-0997-0268
References
- Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. JCO. 2017;35(5):561–564. doi:https://doi.org/10.1200/JCO.2016.71.0947.
- Network NCC. Clinical Practice Guidelines in Oncology-Breast Cancer Version 2. http://wwwnccncom. 2011.
- Zurrida S, Veronesi U. Milestones in breast cancer treatment. Breast J. 2015;21(1):3–12. doi:https://doi.org/10.1111/tbj.12361.
- Kauffmann GW, Moser E, Sauer R. Radiologie: mit 115 Tabellen; Fragen Und Antworten. Elsevier, Urban&FischerVerlag; 2006.
- Indini A, Aschele C, Bruno D, et al. Reorganization of medical oncology departments during COVID-19 pandemic: a nationwide Italian survey. Eur J Cancer. 2020;132:17–23. doi:https://doi.org/10.1016/j.ejca.2020.03.024.
- Indini A, Rijavec E, Ghidini M, et al. Developing a risk assessment score for cancer patients during COVID-19 pandemic. Eur J Cancer. 2020;140:161–162. doi:https://doi.org/10.1016/j.ejca.2020.09.003.
- Bogani G, Ditto A, Bosio S, et al. Cancer patients affected by COVID-19: experience from Milan, Lombardy. Gynecol Oncol. 2020;158(2):262–265. doi:https://doi.org/10.1016/j.ygyno.2020.06.161.
- Bogani G, Apolone G, Ditto A, et al. Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups. J Gynecol Oncol. 2020;31(6):e92. doi:https://doi.org/10.3802/jgo.2020.31.e92.
- Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335–340. doi:https://doi.org/10.1016/0960-7404(93)90064-6.
- Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220(6):759–767. doi:https://doi.org/10.1097/00000658-199412000-00009.
- Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–553. doi:https://doi.org/10.1056/NEJMoa012782.
- Sugie T, Sawada T, Tagaya N, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20(7):2213–2218. doi:https://doi.org/10.1245/s10434-013-2890-0.
- Lin J, Lin L-S, Chen D-R, et al. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer. Asian J Surg. 2020;43(12):1149–1153. doi:https://doi.org/10.1016/j.asjsur.2020.02.003.
- Nielsen KR, Chakera AH, Hesse B, et al. The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging. 2011;38(11):1999–2004. doi:https://doi.org/10.1007/s00259-011-1880-3.
- van der Ploeg IM, Olmos RAV, Kroon BB, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol. 2009;16(6):1537–1542. doi:https://doi.org/10.1245/s10434-009-0339-2.
- Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40(12):1932–1947. doi:https://doi.org/10.1007/s00259-013-2544-2.
- Schmidt M, Bares R, Brenner W, et al. DGN-Handlungsempfehlung (S1-Leitlinie) Verfahrensanweisung für die technische Durchführung der nuklearmedizinischen Wächter-Lymphknoten-Diagnostik. Stand 10/2014–AWMF-Registernummer. [Accessed 2018 Nov 9]. Available. 2014;031–033.
- Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4–16. doi:https://doi.org/10.1002/cncr.21568.
- Dimcheva M, Sergieva S, Robev B. Practical methodology for lymphoscintigraphy and sentinel lymph node biopsy in breast cancer. J Nucl Med. 2020;61:3027–3027.
- Sadeghi R, Zarifmahmoudi L. Application of lymphatic mapping and sentinel node biopsy in surgical oncology. Clinical nuclear medicine. Springer, 2020: 431–458.
- Kuemmel S, Holtschmidt J, Gerber B, et al. Prospective, multicenter, randomized phase III trial evaluating the impact of lymphoscintigraphy as part of sentinel node biopsy in early breast cancer: SenSzi (GBG80) trial. J Clin Oncol. 2019;37(17):1490–1498. doi:https://doi.org/10.1200/JCO.18.02092.